Sign up
Quantellect · Congress · Trade Detail
FARMAPT KALBE (FARMA)
RepublicanHouse

Michael T. McCaul bought PT KALBE (FARMA) (FARMA)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 10 trades in PT KALBE (FARMA) (FARMA) since 2014, 8 purchases and 2 sales, worth an estimated $538K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Michael T. McCaul bought $15,001 - $50,000 of PT KALBE (FARMA) (FARMA) on April 9, 2014. Since that trade, FARMA is up +0.00% against the S&P 500 up +377.91%, an outperformance of -377.91%.

Across these filings, Michael T. McCaul has been a net buyer of FARMA (a buy-to-sell ratio of 4.00). The most recent disclosed FARMA transaction shown was dated April 8, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

FARMA trades
10
Disclosed Vol
$538K
Buys
8
80%
Sells
2
20%
Buy / Sell
4.00
ratio
First → Last
2014–2016

Michael T. McCaul's FARMA trades vs the price

FARMA is up +0.00% since Michael T. McCaul bought on April 9, 2014, versus +377.91% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+377.91%
Outperformance vs S&P 500
-377.91%

All Michael T. McCaul FARMA trades

TradedTypeSizeReturnEst. profit
April 8, 2016BUY$50,001 - $100,000N/A
April 8, 2016BUY$50,001 - $100,000N/A
December 21, 2015SELL$15,001 - $50,000N/A
April 9, 2014BUY$15,001 - $50,000N/A
April 9, 2014BUY$15,001 - $50,000N/A
March 26, 2014SELL$50,001 - $100,000N/A
March 26, 2014BUY$50,001 - $100,000N/A
March 26, 2014BUY$50,001 - $100,000N/A
January 7, 2014BUY$15,001 - $50,000N/A
January 7, 2014BUY$15,001 - $50,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & FARMA trading FAQ

Is it legal for Michael T. McCaul to trade PT KALBE (FARMA) (FARMA) stock?

Yes. Members of Congress are allowed to trade individual stocks, including PT KALBE (FARMA) (FARMA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul buy FARMA?

Michael T. McCaul disclosed a purchase of $15,001 - $50,000 of PT KALBE (FARMA) (FARMA) on April 9, 2014, according to public STOCK Act filings.

How has FARMA performed since Michael T. McCaul's trade?

Since Michael T. McCaul bought FARMA on April 9, 2014, the stock is up +0.00%, versus +377.91% for the S&P 500 over the same period, an outperformance of -377.91%.

How many times has Michael T. McCaul traded FARMA?

Michael T. McCaul has disclosed 10 FARMA trades since 2014 (8 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional FARMA trades?

Quantellect tracks every disclosed congressional trade in PT KALBE (FARMA) (FARMA) on the PT KALBE (FARMA) congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's FARMA tradesAll congressional filings for PT KALBE (FARMA)Michael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.